Literature DB >> 16203960

Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.

Nancy M Petry1, Jessica M Peirce, Maxine L Stitzer, Jack Blaine, John M Roll, Allan Cohen, Jeanne Obert, Therese Killeen, Michael E Saladin, Mark Cowell, Kimberly C Kirby, Robert Sterling, Charlotte Royer-Malvestuto, John Hamilton, Robert E Booth, Marilyn Macdonald, Marc Liebert, Linda Rader, Raynetta Burns, Joan DiMaria, Marc Copersino, Patricia Quinn Stabile, Ken Kolodner, Rui Li.   

Abstract

CONTEXT: Contingency management interventions that provide tangible incentives based on objective indicators of drug abstinence are efficacious in improving outcomes in substance abusers, but these treatments have rarely been implemented in community-based settings.
OBJECTIVE: To evaluate the efficacy of an abstinence-based contingency management intervention as an addition to usual care in community treatment settings.
DESIGN: Random assignment to usual care or usual care plus abstinence-based incentives for 12 weeks.
SETTING: Eight community-based outpatient psychosocial drug abuse treatment programs. PARTICIPANTS: A total of 415 cocaine or methamphetamine users beginning outpatient substance abuse treatment. INTERVENTION: All participants received standard care, and those assigned to the abstinence-based incentive condition also earned chances to win prizes for submitting substance-free urine samples; the chances of winning prizes increased with continuous time abstinent. MAIN OUTCOME MEASURES: Retention, counseling attendance, total number of substance-free samples provided, percentage of stimulant- and alcohol-free samples submitted, and longest duration of confirmed stimulant abstinence.
RESULTS: Participants assigned to the abstinence-based incentive condition remained in treatment for a mean +/- SD of 8.0 +/- 4.2 weeks and attended a mean +/- SD of 19.2 +/- 16.8 counseling sessions compared with 6.9 +/- 4.4 weeks and 15.7 +/- 14.4 sessions for those assigned to the usual care condition (P<.02 for all). Participants in the abstinence-based incentive condition also submitted significantly more stimulant- and alcohol-free samples (P<.001). The abstinence-based incentive group was significantly more likely to achieve 4, 8, and 12 weeks of continuous abstinence than the control group, with odds ratios of 2.5, 2.7, and 4.5, respectively. However, the percentage of positive samples submitted was low overall and did not differ between conditions.
CONCLUSION: The abstinence-based incentive procedure, which provided a mean of 203 dollars in prizes per participant, was efficacious in improving retention and associated abstinence outcomes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16203960     DOI: 10.1001/archpsyc.62.10.1148

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  203 in total

1.  Web-based, psychosocial treatment for substance use disorders in community treatment settings.

Authors:  Aimee N C Campbell; Gloria M Miele; Edward V Nunes; Scott McCrimmon; Udi E Ghitza
Journal:  Psychol Serv       Date:  2012-05

Review 2.  A developmental perspective on neuroeconomic mechanisms of contingency management.

Authors:  Catherine Stanger; Alan J Budney; Warren K Bickel
Journal:  Psychol Addict Behav       Date:  2012-06-04

3.  Contingency management for patients with dual disorders in intensive outpatient treatment for addiction.

Authors:  Thomas M Kelly; Dennis C Daley; Antoine B Douaihy
Journal:  J Dual Diagn       Date:  2014

4.  Financial incentives for abstinence among socioeconomically disadvantaged individuals in smoking cessation treatment.

Authors:  Darla E Kendzor; Michael S Businelle; Insiya B Poonawalla; Erica L Cuate; Anshula Kesh; Debra M Rios; Ping Ma; David S Balis
Journal:  Am J Public Health       Date:  2014-11-13       Impact factor: 9.308

Review 5.  Monetary-based consequences for drug abstinence: methods of implementation and some considerations about the allocation of finances in substance abusers.

Authors:  Jesse Dallery; Bethany Raiff
Journal:  Am J Drug Alcohol Abuse       Date:  2011-12-13       Impact factor: 3.829

6.  Gender differences in the rates and correlates of HIV risk behaviors among drug abusers.

Authors:  Audrey Brooks; Christina S Meade; Jennifer Sharpe Potter; Yuliya Lokhnygina; Donald A Calsyn; Shelly F Greenfield
Journal:  Subst Use Misuse       Date:  2010-06-10       Impact factor: 2.164

7.  Voucher-based reinforcement for alcohol abstinence using the ethyl-glucuronide alcohol biomarker.

Authors:  Michael G McDonell; Donelle N Howell; Sterling McPherson; Jennifer M Cameron; Debra Srebnik; John M Roll; Richard K Ries
Journal:  J Appl Behav Anal       Date:  2012

8.  Facilitating the adoption of contingency management for the treatment of substance use disorders.

Authors:  John M Roll; Gregory J Madden; Richard Rawson; Nancy M Petry
Journal:  Behav Anal Pract       Date:  2009

9.  Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.

Authors:  Sandra D Comer; Warren K Bickel; Richard Yi; Harriet de Wit; Stephen T Higgins; Galen R Wenger; Chris-Ellyn Johanson; Mary Jeanne Kreek
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

10.  Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs?

Authors:  Edward V Nunes; Samuel Ball; Robert Booth; Gregory Brigham; Donald A Calsyn; Kathleen Carroll; Daniel J Feaster; Denise Hien; Robert L Hubbard; Walter Ling; Nancy M Petry; John Rotrosen; Jeffrey Selzer; Maxine Stitzer; Susan Tross; Paul Wakim; Theresa Winhusen; George Woody
Journal:  J Subst Abuse Treat       Date:  2010-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.